IPO Trending
BMLLSME / NSEListed

Bio Medica Laboratories Limited

Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.

₹132 - ₹1392.31x sub
Listed Price111.20
Listing Gain-20.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Nov-25)28.62 Cr
Growth+76.2%
Revenue Trend (₹ in Crores)
0.014.729.444.1Mar-23Mar-24Mar-25Nov-25
PeriodRev (Cr)PAT (Cr)AssetsDebt
Nov-2528.628.6665.1638.16
Mar-2538.329.7939.1115.01
Mar-2415.342.4919.5310.49
Mar-2316.240.3317.569.61
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Nov-259.4454.41%23.24%013.45
Mar-2510.6799.59%48.20%13.030
Mar-242.7267.74%29.92%00
Mar-230.3613.92%10.16%00